vs
NAVIENT CORP（NAVI）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
NAVIENT CORP的季度营收约是RIGEL PHARMACEUTICALS INC的2.0倍（$137.0M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -5.0%，领先389.1%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -38.3%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -30.9%）
纳文特公司是一家总部位于美国特拉华州威尔明顿的金融服务企业，前身是学生贷款服务商。公司于2014年由学生贷款机构萨利美拆分而来，目前在美国各地设有办事处，共有约4500名员工，2018年时曾承接全美四分之一的学生贷款业务，2024年被禁止承接联邦学生贷款业务。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
NAVI vs RIGL — 直观对比
营收规模更大
NAVI
是对方的2.0倍
$69.8M
营收增速更快
RIGL
高出59.5%
-38.3%
净利率更高
RIGL
高出389.1%
-5.0%
两年增速更快
RIGL
近两年复合增速
-30.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $137.0M | $69.8M |
| 净利润 | $-6.0M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | -5.9% | 33.2% |
| 净利率 | -5.0% | 384.0% |
| 营收同比 | -38.3% | 21.2% |
| 净利润同比 | -125.0% | 1769.2% |
| 每股收益（稀释后） | $-0.05 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NAVIRIGL
| Q4 25 | $137.0M | $69.8M | ||
| Q3 25 | $161.0M | $69.5M | ||
| Q2 25 | $156.0M | $101.7M | ||
| Q1 25 | $156.0M | $53.3M | ||
| Q4 24 | $222.0M | $57.6M | ||
| Q3 24 | $396.0M | $55.3M | ||
| Q2 24 | $247.0M | $36.8M | ||
| Q1 24 | $287.0M | $29.5M |
净利润NAVIRIGL
| Q4 25 | $-6.0M | $268.1M | ||
| Q3 25 | $-86.0M | $27.9M | ||
| Q2 25 | $14.0M | $59.6M | ||
| Q1 25 | $-2.0M | $11.4M | ||
| Q4 24 | $24.0M | $14.3M | ||
| Q3 24 | $-2.0M | $12.4M | ||
| Q2 24 | $36.0M | $-1.0M | ||
| Q1 24 | $73.0M | $-8.2M |
毛利率NAVIRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率NAVIRIGL
| Q4 25 | -5.9% | 33.2% | ||
| Q3 25 | -72.7% | 40.9% | ||
| Q2 25 | 11.5% | 60.1% | ||
| Q1 25 | -3.2% | 23.9% | ||
| Q4 24 | 11.7% | 28.9% | ||
| Q3 24 | 3.0% | 25.4% | ||
| Q2 24 | 19.4% | 1.2% | ||
| Q1 24 | 30.7% | -23.6% |
净利率NAVIRIGL
| Q4 25 | -5.0% | 384.0% | ||
| Q3 25 | -53.4% | 40.2% | ||
| Q2 25 | 9.0% | 58.6% | ||
| Q1 25 | -1.3% | 21.5% | ||
| Q4 24 | 10.8% | 24.9% | ||
| Q3 24 | -0.5% | 22.5% | ||
| Q2 24 | 14.6% | -2.8% | ||
| Q1 24 | 25.4% | -27.9% |
每股收益（稀释后）NAVIRIGL
| Q4 25 | $-0.05 | $14.11 | ||
| Q3 25 | $-0.87 | $1.46 | ||
| Q2 25 | $0.13 | $3.28 | ||
| Q1 25 | $-0.02 | $0.63 | ||
| Q4 24 | $0.24 | $0.82 | ||
| Q3 24 | $-0.02 | $0.70 | ||
| Q2 24 | $0.32 | $-0.06 | ||
| Q1 24 | $0.64 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $637.0M | $155.0M |
| 总债务越低越好 | $40.6B | $52.5M |
| 股东权益账面价值 | $2.4B | $391.5M |
| 总资产 | $48.7B | $513.6M |
| 负债/权益比越低杠杆越低 | 16.94× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NAVIRIGL
| Q4 25 | $637.0M | $155.0M | ||
| Q3 25 | $571.0M | $137.1M | ||
| Q2 25 | $712.0M | $108.4M | ||
| Q1 25 | $642.0M | $77.1M | ||
| Q4 24 | $722.0M | $77.3M | ||
| Q3 24 | $1.1B | $61.1M | ||
| Q2 24 | $1.1B | $49.1M | ||
| Q1 24 | $823.0M | $49.5M |
总债务NAVIRIGL
| Q4 25 | $40.6B | $52.5M | ||
| Q3 25 | $41.4B | $60.0M | ||
| Q2 25 | $42.3B | $60.0M | ||
| Q1 25 | $42.9B | $60.0M | ||
| Q4 24 | $43.2B | $60.0M | ||
| Q3 24 | $44.7B | $60.0M | ||
| Q2 24 | $47.5B | $60.0M | ||
| Q1 24 | $50.8B | $60.0M |
股东权益NAVIRIGL
| Q4 25 | $2.4B | $391.5M | ||
| Q3 25 | $2.4B | $117.6M | ||
| Q2 25 | $2.6B | $81.9M | ||
| Q1 25 | $2.6B | $18.6M | ||
| Q4 24 | $2.6B | $3.3M | ||
| Q3 24 | $2.7B | $-14.6M | ||
| Q2 24 | $2.7B | $-29.9M | ||
| Q1 24 | $2.8B | $-31.7M |
总资产NAVIRIGL
| Q4 25 | $48.7B | $513.6M | ||
| Q3 25 | $49.3B | $242.5M | ||
| Q2 25 | $50.2B | $206.7M | ||
| Q1 25 | $51.0B | $176.0M | ||
| Q4 24 | $51.8B | $164.0M | ||
| Q3 24 | $53.4B | $139.4M | ||
| Q2 24 | $56.6B | $128.4M | ||
| Q1 24 | $59.0B | $126.5M |
负债/权益比NAVIRIGL
| Q4 25 | 16.94× | 0.13× | ||
| Q3 25 | 16.98× | 0.51× | ||
| Q2 25 | 16.52× | 0.73× | ||
| Q1 25 | 16.56× | 3.23× | ||
| Q4 24 | 16.35× | 18.25× | ||
| Q3 24 | 16.59× | — | ||
| Q2 24 | 17.30× | — | ||
| Q1 24 | 18.38× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $441.0M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流NAVIRIGL
| Q4 25 | $441.0M | $22.0M | ||
| Q3 25 | $70.0M | $24.0M | ||
| Q2 25 | $126.0M | $30.5M | ||
| Q1 25 | $71.0M | $-893.0K | ||
| Q4 24 | $459.0M | $14.5M | ||
| Q3 24 | $-10.0M | $21.7M | ||
| Q2 24 | $279.0M | $302.0K | ||
| Q1 24 | $182.0M | $-5.0M |
现金转化率NAVIRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | 9.00× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | 19.13× | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | 7.75× | — | ||
| Q1 24 | 2.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
